Omnicell, Inc. (OMCL) Key Metrics
OMCL valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.61B
- Enterprise value
- $1.41B
- P/E (TTM)
- 42.1 10-yr median 111.1
- Forward P/E
- 29.5
- PEG ratio
- 15.40
- Price / sales
- 1.3 10-yr median 2.2
- Price / book
- 1.2 10-yr median 3.3
- EV / EBITDA
- 9.8 10-yr median 26.7
- Dividend yield
- —
- Beta
- 0.99
OMCL key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsOMCL valuation Price multiples at each fiscal year-end price.
OMCL returns How much profit the business earns on the capital it uses.
OMCL per-share figures Results divided by the shares outstanding at year-end.
OMCL financial health Debt, liquidity and how easily interest is covered.
OMCL efficiency & capital use Working capital cycle and where the cash goes.
OMCL valuation history
OMCL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
OMCL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
OMCL cash returned to shareholders
OMCL price vs earnings per share
OMCL key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $2.10B | $2.06B | $1.70B | $2.31B | $8.65B | $5.25B | $3.51B | $2.48B | $1.88B | $1.25B |
| Enterprise value | $2.09B | $2.06B | $1.84B | $2.59B | $8.83B | $5.28B | $3.48B | $2.56B | $2.06B | $1.45B |
| P/E ratio | — | 164.3 | — | 409.7 | 111.1 | 163.1 | 57.2 | 65.8 | 91.1 | — |
| Price / sales | 1.8 | 1.9 | 1.5 | 1.8 | 7.6 | 5.9 | 3.9 | 3.2 | 2.6 | 1.8 |
| Price / book | 1.7 | 1.7 | 1.4 | 2.0 | 7.5 | 5.4 | 4.2 | 3.7 | 3.6 | 2.9 |
| Price / free cash flow | 24.2 | 13.6 | 12.2 | 135.8 | 42.6 | 40.1 | 42.1 | 50.1 | — | 66.6 |
| Price / operating cash flow | 16.5 | 11.0 | 9.4 | 29.7 | 37.3 | 28.2 | 24.2 | 23.9 | 75.6 | 26.1 |
| EV / sales | 1.8 | 1.9 | 1.6 | 2.0 | 7.8 | 5.9 | 3.9 | 3.3 | 2.9 | 2.1 |
| EV / EBITDA | 20.5 | 17.2 | — | 26.7 | 51.0 | 49.3 | 24.4 | 26.7 | 32.8 | 22.4 |
| EV / free cash flow | 24.1 | 13.6 | 13.1 | 151.9 | 43.5 | 40.3 | 41.8 | 51.6 | — | 77.2 |
| Earnings yield | 0.1% | 0.6% | −1.2% | 0.2% | 0.9% | 0.6% | 1.7% | 1.5% | 1.1% | 0.0% |
| Free cash flow yield | 4.1% | 7.3% | 8.2% | 0.7% | 2.3% | 2.5% | 2.4% | 2.0% | −0.3% | 1.5% |
| Dividend yield | — | — | 0.3% | — | — | 2.0% | 0.3% | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 3.7% | 0.0% | 0.7% | 2.3% | 0.2% | 3.0% | 0.6% | 0.0% | 0.0% | 0.3% |
| Share price at fiscal year-end | $45.30 | $44.52 | $37.63 | $50.42 | $180.44 | $120.02 | $81.72 | $61.24 | $48.50 | $33.90 |
| Per share | ||||||||||
| Revenue per share | $25.56 | $24.05 | $25.37 | $28.24 | $23.61 | $20.40 | $20.89 | $19.41 | $18.50 | $18.79 |
| Earnings per share | $0.04 | $0.27 | −$0.45 | $0.12 | $1.62 | $0.74 | $1.43 | $0.93 | $0.53 | $0.02 |
| Operating cash flow per share | $2.75 | $4.06 | $4.01 | $1.69 | $4.84 | $4.25 | $3.38 | $2.56 | $0.64 | $1.30 |
| Free cash flow per share | $1.87 | $3.27 | $3.09 | $0.37 | $4.23 | $2.99 | $1.94 | $1.22 | −$0.15 | $0.51 |
| Cash per share | $4.55 | $8.25 | $10.61 | $7.45 | $7.50 | $11.34 | $3.19 | $1.66 | $0.84 | $1.48 |
| Book value per share | $26.57 | $26.88 | $26.30 | $24.63 | $23.92 | $22.12 | $19.68 | $16.76 | $13.36 | $11.71 |
| Tangible book value per share | $5.81 | $5.66 | $3.88 | $1.57 | $0.69 | $4.71 | $6.96 | $4.93 | $0.29 | −$2.34 |
| Dividends per share | — | — | $0.10 | — | — | $2.41 | $0.23 | — | $0.00 | $0.00 |
| Capex per share | $0.87 | $0.79 | $0.92 | $1.32 | $0.60 | $1.25 | $1.44 | $1.34 | $0.79 | $0.79 |
| Debt per share | $4.41 | $8.27 | $13.58 | $13.44 | $11.28 | $12.08 | $2.58 | $3.56 | $5.43 | $6.89 |
| Shares outstanding | 46.4M | 46.3M | 45.2M | 45.9M | 47.9M | 43.7M | 42.9M | 40.6M | 38.7M | 36.9M |
| Change in shares outstanding | +0.2% | +2.3% | −1.5% | −4.3% | +9.6% | +1.9% | +5.9% | +4.8% | +5.0% | +0.4% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 0.2% | 1.0% | −1.8% | 0.5% | 7.4% | 3.6% | 8.0% | 6.3% | 4.3% | 0.1% |
| Return on invested capital (ROIC) | 0.5% | 0.0% | −2.0% | −0.1% | 7.7% | 3.9% | 8.3% | 6.1% | 0.7% | 1.1% |
| Return on assets (ROA) | 0.1% | 0.6% | −0.9% | 0.3% | 3.9% | 2.1% | 5.3% | 3.7% | 2.2% | 0.1% |
| Return on tangible assets | 0.2% | 1.1% | −1.7% | 0.5% | 7.6% | 3.0% | 8.8% | 6.3% | 4.3% | 0.1% |
| Free cash flow margin | 7.3% | 13.6% | 12.2% | 1.3% | 17.9% | 14.7% | 9.3% | 6.3% | −0.8% | 2.7% |
| Income quality (OCF / net income) | 62.04 | 14.98 | — | 13.77 | 2.98 | 5.77 | 2.36 | 2.76 | 1.21 | 79.50 |
| Financial health | ||||||||||
| Total debt | $204.3M | $382.5M | $614.1M | $616.7M | $541.0M | $528.3M | $110.7M | $144.4M | $210.1M | $254.1M |
| Cash & short-term investments | $211.2M | $381.7M | $479.8M | $341.8M | $359.7M | $496.2M | $137.0M | $67.2M | $32.4M | $54.5M |
| Net debt | −$6.8M | $870,000 | $134.3M | $274.9M | $181.3M | $32.1M | −$26.3M | $77.2M | $177.7M | $199.7M |
| Debt / equity | 0.17 | 0.31 | 0.52 | 0.55 | 0.47 | 0.55 | 0.13 | 0.21 | 0.41 | 0.59 |
| Debt / assets | 0.10 | 0.18 | 0.28 | 0.28 | 0.25 | 0.29 | 0.09 | 0.13 | 0.21 | 0.27 |
| Net debt / EBITDA | −0.07 | 0.01 | — | 2.84 | 1.05 | 0.30 | −0.18 | 0.81 | 2.84 | 3.08 |
| Current ratio | 1.43 | 1.37 | 2.52 | 2.06 | 0.89 | 3.00 | 2.04 | 1.94 | 1.73 | 1.74 |
| Quick ratio | 1.22 | 1.22 | 2.22 | 1.71 | 0.75 | 2.65 | 1.58 | 1.45 | 1.28 | 1.36 |
| Interest coverage | 3.0 | 0.1 | -2.4 | -17.9 | 4.0 | 16.9 | 13.5 | 5.1 | 0.9 | 0.8 |
| Working capital | $203.5M | $219.8M | $559.8M | $453.4M | −$95.5M | $553.0M | $246.2M | $192.6M | $154.6M | $134.5M |
| Invested capital | $1.22B | $1.24B | $1.32B | $1.41B | $1.33B | $999.6M | $819.0M | $756.8M | $694.9M | $631.3M |
| Tangible asset value | $269.6M | $261.9M | $175.3M | $72.2M | $33.2M | $206.0M | $298.8M | $200.0M | $11.3M | −$86.4M |
| Net current asset value | −$62.8M | −$62.2M | −$110.4M | −$198.8M | −$215.1M | −$27.6M | $87.7M | −$4.5M | −$96.0M | −$188.1M |
| Graham number | $5.14 | $12.80 | — | $8.26 | $29.56 | $19.14 | $25.15 | $18.73 | $12.65 | $2.08 |
| Graham net-net per share | −$6.87 | −$5.61 | −$6.95 | −$9.60 | −$8.25 | −$3.89 | −$0.95 | −$3.37 | −$6.03 | −$8.18 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | $4.4M | — | — | $105.6M | $9.7M | — | $0 | $0 |
| Share buybacks (net) | $77.6M | $0 | $7.4M | $52.2M | $16.3M | $53.0M | $9.7M | $0 | $0 | $3.5M |
| Dividend payout ratio | — | — | — | — | — | 327.9% | 15.8% | — | 0.0% | 0.0% |
| Dividends + buybacks / free cash flow | 89.3% | 0.0% | 8.4% | 306.4% | 8.0% | 121.1% | 23.2% | 0.0% | — | 18.6% |
| Capex / revenue | 3.4% | 3.3% | 3.6% | 4.7% | 2.6% | 6.1% | 6.9% | 6.9% | 4.3% | 4.2% |
| Capex / operating cash flow | 31.7% | 19.4% | 22.9% | 78.1% | 12.5% | 29.5% | 42.5% | 52.3% | 123.0% | 60.8% |
| Capex / depreciation | 0.47 | 0.41 | 0.43 | 0.61 | 0.34 | 0.77 | 0.96 | 1.06 | 0.59 | 0.50 |
| Stock-based compensation / revenue | 3.8% | 3.5% | 4.8% | 5.3% | 4.7% | 5.0% | 3.8% | 3.7% | 3.1% | 2.8% |
| R&D / revenue | 7.4% | 8.1% | 8.5% | 8.1% | 6.7% | 7.9% | 7.7% | 8.2% | 9.2% | 8.3% |
| SG&A / revenue | 34.6% | 34.2% | 40.5% | 37.5% | 34.4% | 34.5% | 32.3% | 33.4% | 35.0% | 36.0% |
| Efficiency | ||||||||||
| Days sales outstanding | 72.9 | 83.4 | 87.7 | 76.1 | 69.5 | 83.6 | 84.4 | 91.6 | 89.0 | 68.0 |
| Days of inventory on hand | 51.1 | 56.6 | 72.3 | 69.0 | 68.3 | 77.9 | 82.8 | 86.6 | 76.6 | 55.8 |
| Days payables outstanding | 25.8 | 27.6 | 30.4 | 34.8 | 35.3 | 33.0 | 33.5 | 38.0 | 34.9 | 24.0 |
| Cash conversion cycle (days) | 98.2 | 112.4 | 129.6 | 110.3 | 102.5 | 128.4 | 133.7 | 140.2 | 130.7 | 99.9 |
| Receivables turnover | 5.01 | 4.38 | 4.16 | 4.80 | 5.25 | 4.37 | 4.33 | 3.99 | 4.10 | 5.36 |
| Payables turnover | 14.13 | 13.25 | 12.00 | 10.48 | 10.33 | 11.05 | 10.90 | 9.61 | 10.46 | 15.24 |
| Inventory turnover | 7.14 | 6.45 | 5.05 | 5.29 | 5.34 | 4.69 | 4.41 | 4.21 | 4.76 | 6.54 |
| Asset turnover | 0.58 | 0.51 | 0.52 | 0.60 | 0.57 | 0.58 | 0.77 | 0.76 | 0.75 | 0.92 |
| Average receivables | $236.6M | $254.2M | $275.7M | $270.2M | $215.5M | $204.2M | $207.3M | $197.5M | $174.6M | $129.1M |
| Average payables | $47.9M | $48.4M | $54.2M | $67.5M | $55.9M | $43.3M | $42.2M | $43.2M | $37.7M | $24.9M |
| Average inventory | $94.8M | $99.4M | $128.8M | $133.7M | $108.1M | $102.2M | $104.4M | $98.5M | $82.7M | $57.9M |
| Intangibles / total assets | 48.7% | 46.3% | 45.5% | 47.9% | 52.0% | 41.7% | 44.0% | 44.4% | 51.6% | 55.4% |
Computed from OMCL's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
OMCL valuation and financial ratios
Based on the latest twelve months, the trailing P/E is 42.1 and the forward P/E is 29.5. Omnicell earned a return on equity of 0.2% and a return on invested capital of 0.5% in fiscal 2025. It ended the year with $204.3 million of debt and $211.2 million in cash and short-term investments, a net cash position of $6.8 million. It returned $77.6 million to shareholders: $0 in dividends and $77.6 million in share buybacks, 89% of free cash flow. The share count rose 25.8% from 36.9M to 46.4M over 9 years.
See the OMCL income statement, the OMCL chart for price history, or the OMCL stock overview for the latest quote and news.
OMCL key metrics FAQ
What is Omnicell's P/E ratio?
Omnicell's trailing P/E ratio is 42.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 29.5. At the end of fiscal 2025 it was —, compared with a 10-year median of 111.1.
What is Omnicell's EV/EBITDA?
Omnicell's enterprise value was 20.5 times EBITDA at the end of fiscal 2025 (enterprise value $2.1 billion, EBITDA $101.9 million); the current EV/EBITDA is 9.8.
What is Omnicell's return on equity?
Omnicell's return on equity (ROE) was 0.2% in fiscal 2025: net income of $2.1 million on average shareholders' equity of $1.2 billion.
What is Omnicell's ROIC?
Omnicell's return on invested capital was 0.5% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Omnicell have?
Omnicell had total debt of $204.3 million at the end of fiscal 2025, a debt-to-equity ratio of 0.17 and more cash than debt.
Does Omnicell buy back its shares?
Yes. Omnicell spent $77.6 million on net share repurchases in fiscal 2025 Shares outstanding changed +0.2% over the year, to 46.4M..
What is Omnicell's free cash flow yield?
Omnicell generated $86.9 million of free cash flow in fiscal 2025, a free cash flow yield of 4.1% on its market value at year-end ($2.1 billion).
What is Omnicell's current ratio?
Omnicell's current ratio was 1.43 at the end of fiscal 2025: current assets were 1.43 times current liabilities.